NCT02805361View on ClinicalTrials.gov

Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

511

Participants

Timeline

Start Date

August 21, 2016

Primary Completion Date

July 13, 2018

Study Completion Date

July 13, 2018

Conditions
Type II Diabetes Mellitus
Trial Locations (4)

Unknown

Research Site, Kuwait City

Research Site, Abu Dhabi

Research Site, Ajman

Research Site, Dubai

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY